Testing AI for reading prostate MRI scans
Part of Cancer, Kidney & urinary clinical trials.
This study uses an artificial intelligence (AI) program to read MRI scans of the prostate and compare its findings with those of expert radiologists. The goal is to see if the AI can detect prostate cancer as accurately as the human experts, which might help in future diagnosis and treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 20 years or older.
- You need to have had a multiparametric MRI of your prostate within the last year.
- For the biopsy group: You must be scheduled to have a prostate biopsy as part of your standard care.
- For the surgery group: You must be scheduled to have your prostate removed (radical prostatectomy) as your primary treatment.
- You must not have been treated for prostate cancer before.
- You must not have had previous surgery for an enlarged prostate (benign prostatic hyperplasia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a computer (AI) can better sort MRI results to improve prostate cancer diagnosis or classification. You may benefit by getting your multi-part MRI looked at in a new, more precise way, while helping researchers refine decision-making.
This trial tests whether an artificial intelligence (AI) program can help doctors decide when a prostate biopsy is needed. It is for men who have had a prostate MRI that shows either a low-risk (PIRADS 1-2) or uncertain (PIRADS 3) spot, along with a higher-than-normal PSA level. You may qualify if you have certain risk factors like a high PSA density, suspicious digital rectal exam, or family history of prostate cancer.
This study compares how well a doctor’s MRI reading (the PI-RADS score) and a computer AI tool detect prostate cancer. It may help improve how men get targeted biopsies and avoid missing important cancers.
This study uses artificial intelligence to look at your MRI scans, tissue samples, and medical records to learn more about prostate cancer and find better ways to treat it. You may join if you've had prostate removal surgery or have advanced prostate cancer.
This study compares how artificial intelligence and doctors interpret prostate MRI scans to improve cancer detection and guide treatment decisions. You'll have an MRI scan and possibly a biopsy to help researchers understand which approach works best.
This study is testing whether artificial intelligence can better predict prostate cancer by combining two types of scans (MRI and PSMA PET) along with your medical history, PSA, and biopsy results. If you have already had these scans and a biopsy, your information may help researchers develop a more accurate, non-invasive diagnostic tool.
Hear when a new Prostate Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.